Element Capital Management’s Gilead Sciences GILD Stock Holding History

Element Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-24,959	Closed	-$2.8M	–	67
2025 Q1	$2.8M	Buy	+24,959	New	+$2.58M	0.7%	19
2022 Q4	–	Sell	-31,743	Closed	-$1.96M	–	72
2022 Q3	$1.96M	Hold	31,743	–	–	0.94%	34
2022 Q2	$1.96M	Buy	31,743 +10,581	+50%	+$655K	0.98%	29
2022 Q1	$1.26M	Buy	+21,162	New	+$1.35M	0.63%	41
2019 Q4	–	Sell	-46,646	Closed	-$2.96M	–	111
2019 Q3	$2.96M	Buy	+46,646	New	+$3.05M	0.26%	88
2019 Q2	–	Sell	-3,857	Closed	-$251K	–	435
2019 Q1	$251K	Sell	3,857 -52,796	-93%	-$3.51M	0.01%	656
2018 Q4	$3.54M	Sell	56,653 -20,978	-27%	-$1.47M	0.1%	154
2018 Q3	$5.99M	Buy	77,631 +19,506	+34%	+$1.47M	0.12%	148
2018 Q2	$4.12M	Buy	58,125 +38,993	+204%	+$2.75M	0.11%	85
2018 Q1	$1.44M	Buy	+19,132	New	+$1.52M	0.03%	168
2016 Q3	–	Sell	-13,151	Closed	-$1.1M	–	107
2016 Q2	$1.1M	Buy	+13,151	New	+$1.17M	0.17%	90

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Element Capital Management's GILD Position: Q2 2025 in Review

Element Capital Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 24,959 shares — an estimated $2.8M sold.

Element Capital Management first reported a position in GILD in Q2 2016 and held it in 11 quarters. The position peaked at $5.99M in Q3 2018. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Element Capital Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
Element Capital Management sold 24,959 Gilead Sciences shares in Q2 2025, an estimated $2.8M.
Element Capital Management first reported a position in Gilead Sciences in Q2 2016 and held it in 11 quarters.
Element Capital Management's Gilead Sciences position peaked at $5.99M in Q3 2018.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Element Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.